TARRYN TRAN: Open Payments
NPI 1285086686 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,180 in 74 payments from 10 companies in 2025. Trend: 2023 $987 · 2024 $1,255 · 2025 $2,180
Food & beverage: $2,081Education: $99
| Company | Payments | Amount |
|---|---|---|
| Biogen, Inc. | 26 | $557 |
| MAYNE PHARMA COMMERCIAL LLC | 12 | $547 |
| Sumitomo Pharma America, Inc. | 7 | $435 |
| Astellas Pharma US Inc | 6 | $228 |
| MILLICENT US INC | 11 | $181 |
| Exeltis, USA Inc. | 6 | $108 |
| Dexcom, Inc. | 2 | $45 |
| Evofem Biosciences, Inc. | 2 | $42 |
| CooperSurgical, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
Products named: ZURZUVAE, MYFEMBREE, Veozah, BIJUVA, ANNOVERA, SLYND, GEMTESA, FEMRING.
Industry payments across CA — which companies pay providers there.
